Idorsia Pharmaceuticals Us Inc. company information, Employees & Contact Information

Idorsia announces financial results for the first quarter GlobeNewswire

FDA removes REMS requirement from Idorsia’s Tryvio label The Pharma Letter

Idorsia Therapeutics Poised to Cut Hundreds of Jobs in Restructuring DELCO.Today

Idorsia's once-daily TRYVIO™ (aprocitentan) is now available in the U.S., advancing treatment options for millions of patients with difficult-to-control hypertension PR Newswire

Amid cost cuts, job losses, Idorsia nears global deal for hypertension drug Tryvio FirstWord Pharma

US FDA approves an updated label for TRYVIO (aprocitentan) removing the REMS requirement GlobeNewswire

Idorsia's insomnia drug Quviviq hits the market with 500 sales reps and plans for 'robust' DTC campaign Fierce Pharma

Rising to the Task Pharmaceutical Executive

FDA approves new hypertension drug months after Idorsia reacquired rights for $343M Cardiovascular Business

Idorsia announces its insomnia medication, QUVIVIQ (daridorexant), is now covered by CVS BioSpace

FDA Approves Aprocitentan (Tryvio) for Treatment-Resistant Hypertension HCPLive

US FDA removes REMS requirement for TRYVIO (aprocitentan) – GlobeNewswire

Idorsia, with U.S. operations on the Main Line, expects to cut hundreds of jobs The Business Journals

Tausif ('Tosh') Butt to Join Idorsia Pharmaceuticals U.S. as President and General Manager PR Newswire

Idorsia announces financial results for 2024 GlobeNewswire

US FDA approves Idorsia's once-daily TRYVIO (aprocitentan) - the first and only endothelin receptor antagonist for the treatment of high blood pressure not adequately controlled in combination with other antihypertensives PR Newswire

Idorsia Files Petition with the Drug Enforcement Administration (DEA) Urging Them to De-Schedule Dual Orexin Receptor Antagonist Class of Insomnia Medications PR Newswire

Idorsia announces financial results for the first nine months of 2024 GlobeNewswire

Idorsia reaches an agreement with significant bondholders GlobeNewswire

Idorsia's Tryvio crosses FDA finish line, offering new mechanism to treat hypertension Fierce Pharma

FDA Approves Aprocitentan for Inadequately Controlled Hypertension TCTMD.com

Idorsia receives US FDA approval of QUVIVIQ (daridorexant) 25 and 50 mg for the treatment of adults with insomnia PR Newswire

Idorsia Announces Esteemed Actor, Author and Father, Taye Diggs, as Patient Ambassador for QUVIVIQ™ (daridorexant), a Once Nightly Treatment for Insomnia PR Newswire

Idorsia Wins FDA Approval in Hypertension Months After J&J Returned Rights to Drug BioSpace

Idorsia's recently approved insomnia drug Quviviq hits the shelves The Business Journals

Idorsia taps more star power, enlisting actor Taye Diggs to pitch newly launched insomnia drug Quviviq Fierce Pharma

Idorsia Announces World Champion Skier, Philanthropist and Entrepreneur Lindsey Vonn as Patient Ambassador for QUVIVIQ™ (daridorexant), a Once Nightly Treatment for Insomnia PR Newswire

A Sleeping Giant?: Quviviq Pharmaceutical Executive

Idorsia shares sink on ‘unexpected’ failure of drug study BioPharma Dive

Why Jennifer Aniston is helping a Main Line pharmaceutical firm take on insomnia The Business Journals

Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck's Belsomra, Eisai's Dayvigo Fierce Pharma

Idorsia taps Olympic gold medalist Lindsey Vonn as its latest celebrity spokeswoman Fierce Pharma

Jennifer Aniston Struggles with Sleep in Pharmaceutical Brand Idorsia’s Campaign from Taika Waititi Little Black Book | LBBOnline

Lindsey Vonn becomes latest celebrity to tout Main Line firm's new insomnia treatment The Business Journals

Jennifer Aniston Works on Commercial for Radnor Pharmaceutical Idorsia DELCO.Today

FDA approves insomnia drug developed by Swiss company with Main Line operations The Business Journals

Taika Waititi Directs Jennifer Aniston In Idorsia Spot For Goodby Silverstein SHOOTonline

Jennifer Aniston Confronts Insomnia—and Herself—in Funny and Relatable Ad ADWEEK

Swiss drugmaker Idorsia's insomnia medicine gets US FDA's approval Business Standard